Back to search

Article

CIP2A promotes osteoclastogenesis and postmenopausal bone loss by activating a novel HMGA1–c-Myc–PI3K/AKT axis

2026-08-20

Abstract excerpt

<title>Abstract</title> <p>Background Osteoclast-mediated bone resorption drives osteoporosis, a prevalent skeletal disorder with significant clinical and socioeconomic burden, yet the upstream molecular mechanisms controlling osteoclast differentiation remain incompletely defined. Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a known oncogenic regulator, but its role in bone metabolism and osteoclast...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3cc238b1-bc50-50c1-b512-7eb1fc34cc55
DOI
10.21203/rs.3.rs-9848947/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CIP2A promotes osteoclastogenesis and postmenopausal bone loss by activating a novel HMGA1–c-Myc–PI3K/AKT axisDOI 10.21203/rs.3.rs-9848947/v1
Select a neighboring publication to make it the new centre.